CBP Issues Guidance on COVID-19 Section 301 Exclusion Extensions

Posted by Kelsay Calvaruso on 12/1/22 5:00 PM

On December 1, 2022, in Cargo Systems Messaging Service (CSMS) #54197079, U.S. Customs and Border Protection (CBP) issued guidance on the extensions of 81 Section 301 medical product exclusions related to the COVID-19 pandemic.

The extensions were announced by the Office of the U.S. Trade Representative (USTR) on November 29, 2022. The extensions will be valid through February 28, 2023.

CBP directs additional questions on Section 301 entry filing requirements to TradeRemedy@cbp.dhs.gov.

CSMS #54197079 can be found here:

https://content.govdelivery.com/bulletins/gd/USDHSCBP-33afb57?wgt_ref=USDHSCBP_WIDGET_2

USTR’s notice can be found here:

https://www.federalregister.gov/documents/2022/11/29/2022-25990/notice-of-product-exclusion-extensions-chinas-acts-policies-and-practices-related-to-technology

Topics: China, CBP, Exclusions, Trade Remedies

Expeditors' Newsflash articles are compiled from a number of public sources that, to the best of Expeditors' knowledge, are true and correct. It is our intent to present only accurate information. However, in the event any information contained herein is erroneous, Expeditors International of  Washington, Inc. accepts no liability or responsibility.                                                                                           

Copyright © Expeditors International of Washington, Inc.  Expeditors' Newsflash articles may not be reproduced in any form without advanced written consent of an authorized officer of the copyright holder.     

Recommended for you